Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis
Hsin-Yuan Cheng, Dalia E. Gaddis, Runpei Wu, Chantel McSkimming, LaTeira D. Haynes, Angela M. Taylor, Coleen A. McNamara, Mary Sorci-Thomas, Catherine C. Hedrick
Hsin-Yuan Cheng, Dalia E. Gaddis, Runpei Wu, Chantel McSkimming, LaTeira D. Haynes, Angela M. Taylor, Coleen A. McNamara, Mary Sorci-Thomas, Catherine C. Hedrick
View: Text | PDF
Research Article Inflammation

Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis

  • Text
  • PDF
Abstract

ATP-binding cassette transporter G1 (ABCG1) promotes cholesterol accumulation and alters T cell homeostasis, which may contribute to progression of atherosclerosis. Here, we investigated how the selective loss of ABCG1 in T cells impacts atherosclerosis in LDL receptor–deficient (LDLR-deficient) mice, a model of the disease. In LDLR-deficient mice fed a high-cholesterol diet, T cell–specific ABCG1 deficiency protected against atherosclerotic lesions. Furthermore, T cell–specific ABCG1 deficiency led to a 30% increase in Treg percentages in aorta and aorta-draining lymph nodes (LNs) of these mice compared with animals with only LDLR deficiency. When Abcg1 was selectively deleted in Tregs of LDLR-deficient mice, we observed a 30% increase in Treg percentages in aorta and aorta-draining LNs and reduced atherosclerosis. In the absence of ABCG1, intracellular cholesterol accumulation led to downregulation of the mTOR pathway, which increased the differentiation of naive CD4 T cells into Tregs. The increase in Tregs resulted in reduced T cell activation and increased IL-10 production by T cells. Last, we found that higher ABCG1 expression in Tregs was associated with a higher frequency of these cells in human blood samples. Our study indicates that ABCG1 regulates T cell differentiation into Tregs, highlighting a pathway by which cholesterol accumulation can influence T cell homeostasis in atherosclerosis.

Authors

Hsin-Yuan Cheng, Dalia E. Gaddis, Runpei Wu, Chantel McSkimming, LaTeira D. Haynes, Angela M. Taylor, Coleen A. McNamara, Mary Sorci-Thomas, Catherine C. Hedrick

×

Figure 6

Absence of ABCG1 results in increased cellular cholesterol and lipid rafts, inhibition of mTOR signaling, and increased p-STAT5 signaling.

Options: View larger image (or click on image) Download as PowerPoint
Absence of ABCG1 results in increased cellular cholesterol and lipid raf...
(A–C) Cholesterol content using filipin staining (A) p-S6 (B) and p-STAT5 (C) in Lck-Cre+ Abcg1fl/fl Ldlr–/– Tregs compared with Tregs from Lck-Cre– Abcg1fl/fl Ldlr–/– littermates. Cells were isolated from aortic LNs in A–C and were stimulated with 100 U/ml IL-2 for 15 minutes in B and C. Red line indicates Lck-Cre+ Abcg1fl/fl Ldlr–/– Tregs; black line indicates Lck-Cre– Abcg1fl/fl Ldlr–/– Tregs. An unstimulated sample is shown in gray in B and C. Results are shown for individual mice. N = 5–6 mice per group. (D) Filipin staining showed an increase in intracellular cholesterol in Tregs in aortic LNs from Foxp3-Cre+ Abcg1fl/fl Ldlr–/– mice (red) compared with Ldlr–/– control mice (black) following 15 weeks of high-cholesterol diet feeding. Results are shown for individual mice. N = 4–5 mice per group. (E–F) Foxp3-Cre+ Abcg1fl/fl Ldlr–/– and Foxp3-Cre+ Ldlr–/– control mice were fed a high-cholesterol diet for 15 weeks, and lipid rafts and p-S6 were measured in Tregs in the aortic LNs. Plots represent 2 separate experiments (Exp1 and Exp2). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by unpaired Student’s t test to determine differences between 2 groups.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts